Genetic engineering of a modified herpes simplex virus 1 vaccine vector. - Wikidata - wikimedia - TriplyDB

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

http://www.wikidata.org/entity/Q37188682

about

Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p HSV Recombinant Vectors for Gene Therapy.Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.Viral vectors and delivery strategies for CNS gene therapy.Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79.Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells.Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.

P2860

Q35111489-A897F10B-744E-4EF6-9DE3-FBA16F9D9FB7 Q37365353-8F7A9278-01DD-4FE0-9233-3D7FDF7F39B4 Q37787777-4194429E-7354-4F84-B09A-2574362323BE Q37837495-5AB8A3CD-9B82-4A85-AB66-CFBC59ABB97B Q38029645-C1750937-D816-4129-97C9-A23A31E7E2F0 Q38788289-4C2B8408-893F-460D-8701-E67E57E7E391 Q38850997-4C3C589D-4A61-4FDE-ADE1-F29FA6C6E370 Q42209919-C1BBCF98-D79C-45CE-A2A6-C06B3F294D28 Q45370073-6F238B02-EAB8-4EEE-B929-76DAFF629903

P2860

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

http://www.wikidata.org/entity/Q37188682

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@en

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@nl

type

label

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@en

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@nl

prefLabel

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@en

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

@nl

P1433

Q37188682-7B98FE7E-9ADF-4919-9824-55FFC66FA094

P1476

Q37188682-4C622101-0430-4B29-B350-ADFF94E02D28

P2093

Q37188682-2E06B01A-A51C-4093-AB2A-F2D21C1D189A

Q37188682-5C5B3D79-EE79-4944-B372-94F60D41806C

Q37188682-80F6FDEE-A374-4A1C-9BF3-9E649197DA03

Q37188682-E65BE5B9-8170-46EA-BC4F-2C111697BC2E

Q37188682-F7419E42-0798-43A2-AD6B-37FFD481AAF6

P2860

Q37188682-053B6F03-E028-4925-8171-53A40FF207B9

Q37188682-1333D293-CE0F-4897-AE59-801AF0D7D149

Q37188682-1CAE3945-B722-4D6D-949F-0BB822045AE4

Q37188682-1F05254A-0D53-4D6A-B639-F418C326DC91

Q37188682-2E0A5C46-E9B9-4CB8-B62F-184E2DE5B5F9

Q37188682-36C9B5E7-C6A6-4B60-873E-1AE5938E56E2

Q37188682-37CE5192-D612-4293-A3F4-D5E5AD990998

Q37188682-38C22BAD-8E04-4283-AF18-5E47B310A63B

Q37188682-3ABB7A32-E39F-4329-93E0-C54E21182B7F

Q37188682-40759F8E-2B08-4D36-90D0-993B2C1882FB

P304

Q37188682-6DB54757-61D3-45F9-B3C5-83CB6B4B8043

P31

Q37188682-1529F886-E228-44FD-9F8B-7157F6EA503D

P356

Q37188682-5CB2ACDB-A2BF-49AE-B4A8-EFF4BEC7B07F

P407

Q37188682-8C9E2658-0EE1-44A5-BCAD-C38489F8D8EB

P433

Q37188682-E2279E57-AAC4-4DDA-A812-F1C0C686F388

P478

Q37188682-E4DFE3A5-411B-4BDE-B299-16E1D780B282

P50

Q37188682-CAC436A1-C2AA-4D4F-AC1A-E61B07677C0F

P577

Q37188682-7FE844CF-FBCF-42BD-8778-9AEA20A4C12F

P5875

Q37188682-8204EB91-6CB6-4077-9D94-B9DD766A6150

P698

Q37188682-676CB654-D306-46D1-B044-F4E5F3148CC0

P921

Q37188682-FD3C855E-8078-4DE4-96CA-1904B31044EF

P932

Q37188682-93BEA089-E893-463F-8EEA-F6A08CABCBA8

P356

J.VACCINE.2009.03.003

P1433

P1476

Genetic engineering of a modified herpes simplex virus 1 vaccine vector

@en

P2093

David M Knipe

http://www.w3.org/2001/XMLSchema#string

Eeva Broberg

http://www.w3.org/2001/XMLSchema#string

Neal Deluca

http://www.w3.org/2001/XMLSchema#string

Timothy Dudek

http://www.w3.org/2001/XMLSchema#string

Xueqiao Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex

Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-

Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins.

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.

Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.

Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239

Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

P304

2760-2767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.03.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Daisuke Watanabe

P577

2009-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24414555

http://www.w3.org/2001/XMLSchema#string

P698

19428888

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

2680798

http://www.w3.org/2001/XMLSchema#string